Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 420 | 210 | 222 | 153 | 173 |
| Receivables | 44 | 21 | 135 | 54 | N/A |
| Inventories | 291 | 430 | 474 | 189 | 162 |
| TOTAL | $870 | $825 | $1,017 | $607 | $668 |
| Non-Current Assets | |||||
| PPE Net | 926 | 1,283 | 1,150 | 1,038 | 287 |
| Other Non-Current Assets | 35 | 0 | 0 | 0 | 0 |
| TOTAL | $961 | $1,283 | $1,150 | $1,038 | $287 |
| Total Assets | $1,830 | $2,108 | $2,167 | $1,645 | $954 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 200 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 244 | 292 | 312 | 355 | 88 |
| Accrued Expenses | 469 | 422 | 253 | 233 | 206 |
| Other current liabilities | 85 | 278 | 429 | N/A | N/A |
| TOTAL | $1,001 | $992 | $994 | $589 | $294 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 81 | 0 | 0 | 0 |
| TOTAL | $15 | $99 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,015 | $1,091 | $994 | $589 | $294 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 128,668 | 90,605 | 89,719 | 85,317 | 84,468 |
| Common Shares | 10 | 9 | 9 | 9 | 8 |
| Retained earnings | -34,834 | -34,313 | -33,596 | -33,373 | -32,759 |
| TOTAL | $815 | $1,017 | $1,173 | $1,057 | $661 |
| Total Liabilities And Equity | $1,830 | $2,109 | $2,167 | $1,645 | $954 |